Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Midlife Cholesterol Study

Phase 4

Completed

Conditions: Menopause
Postmenopause
Premenopause
Cardiovascular Disease

First Posted Date: 2006-08-07

Last Posted Date: 2014-11-05

Lead Sponsor: Northwestern University

Target Recruit Count: 120

Registration Number: NCT00361075

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors
Sarcoma

Interventions: Drug: vatalanib

First Posted Date: 2006-07-06

Last Posted Date: 2018-10-26

Lead Sponsor: Northwestern University

Target Recruit Count: 25

Registration Number: NCT00348790

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸
University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States

Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin

Phase 4

Completed

Conditions: Hyperglycemia
Diabetes

Interventions: Drug: insulin glargine

First Posted Date: 2006-06-20

Last Posted Date: 2009-04-06

Lead Sponsor: Northwestern University

Target Recruit Count: 75

Registration Number: NCT00338104

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Biological: bevacizumab

First Posted Date: 2006-06-15

Last Posted Date: 2020-02-07

Lead Sponsor: Northwestern University

Target Recruit Count: 55

Registration Number: NCT00337207

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States

Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Lung Cancer

First Posted Date: 2006-06-08

Last Posted Date: 2012-07-10

Lead Sponsor: Northwestern University

Target Recruit Count: 32

Registration Number: NCT00334763

Locations: 🇺🇸
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Evanston Northwestern Healthcare - Evanston Hospital, Evanston, Illinois, United States

and more 2 locations

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: lapatinib ditosylate
Drug: paclitaxel albumin-stabilized nanoparticle formulation

First Posted Date: 2006-05-31

Last Posted Date: 2020-03-06

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT00331630

Locations: 🇺🇸
Northwestern University, Northwestern Medical Faculty Foundation, Chicago, Illinois, United States
🇺🇸
Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸
Midwest Center for Hematology/Oncology, Joliet, Illinois, United States

and more 2 locations

Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: lapatinib ditosylate
Drug: Doxil

First Posted Date: 2006-04-21

Last Posted Date: 2013-11-08

Lead Sponsor: Northwestern University

Target Recruit Count: 23

Registration Number: NCT00316875

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Translating the DPP Into the Community

Not Applicable

Completed

Conditions: Prediabetic State
Overweight
Obesity

Interventions: Behavioral: Brief Counseling for pre-diabetes alone
Behavioral: Brief counseling plus group diabetes prevention in community

First Posted Date: 2006-03-13

Last Posted Date: 2017-07-18

Lead Sponsor: Northwestern University

Target Recruit Count: 92

Registration Number: NCT00302042

Locations: 🇺🇸
Indiana University Diabetes Prevention and Control Center, Indianapolis, Indiana, United States

Feasibility of a Partnered Approach to Prevent Diabetes

Not Applicable

Completed

Conditions: Obesity
Pre-diabetic State
Overweight

Interventions: Behavioral: Clinical referral to group diabetes prevention lifestyle
Behavioral: Clinical referral to diabetes prevention lifestyle

First Posted Date: 2006-03-13

Last Posted Date: 2016-12-01

Lead Sponsor: Northwestern University

Target Recruit Count: 72

Registration Number: NCT00302055

Locations: 🇺🇸
IU Medical Group Banta Road Clinic, Indianapolis, Indiana, United States
🇺🇸
IU Medical Group Westside Clinic, Indianapolis, Indiana, United States

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

Phase 3

Terminated

Conditions: Neurotoxicity
Pain
Breast Cancer

Interventions: Other: Placebo
Drug: D-cycloserine

First Posted Date: 2006-03-10

Last Posted Date: 2013-12-02

Lead Sponsor: Northwestern University

Target Recruit Count: 7

Registration Number: NCT00301080

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Wisconsin School of Medicine, Madison, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy